Published in Nucl Med Biol on March 03, 2012
Prospective of ⁶⁸Ga-radiopharmaceutical development. Theranostics (2013) 1.32
PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments. Biomed Res Int (2014) 0.98
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. Inorg Chem (2012) 0.91
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu. Dalton Trans (2014) 0.91
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy. J Am Chem Soc (2013) 0.83
New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). Bioconjug Chem (2015) 0.81
Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate. EJNMMI Res (2015) 0.77
"One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology. Int J Nanomedicine (2013) 0.77
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry. Inorg Chem (2014) 0.76
Re-assessing gallium-67 as a therapeutic radionuclide. Nucl Med Biol (2016) 0.75
Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68. Bioconjug Chem (2016) 0.75
Metal complexes in medicinal chemistry: new vistas and challenges in drug design. Dalton Trans (2005) 1.61
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry (2010) 1.45
Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev (2009) 1.30
SNAP: Combine and Map modules for multilocus population genetic analysis. Bioinformatics (2006) 1.29
Vanadium in diabetes: 100 years from Phase 0 to Phase I. J Inorg Biochem (2006) 1.28
Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J Am Chem Soc (2008) 1.28
Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem (2008) 1.27
Arylfluoroborates and alkylfluorosilicates as potential PET imaging agents: high-yielding aqueous biomolecular 18F-labeling. J Am Chem Soc (2005) 1.23
Matching chelators to radiometals for radiopharmaceuticals. Chem Soc Rev (2013) 1.20
Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. Dalton Trans (2008) 1.10
Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J Am Chem Soc (2007) 1.10
Substituent effects on aryltrifluoroborate solvolysis in water: implications for Suzuki-Miyaura coupling and the design of stable (18)F-labeled aryltrifluoroborates for use in PET imaging. J Org Chem (2008) 1.06
Carbohydrate-appended 2,2'-dipicolylamine metal complexes as potential imaging agents. Inorg Chem (2005) 1.05
Metal complexes of maltol and close analogues in medicinal inorganic chemistry. Chem Soc Rev (2006) 1.05
Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III). Inorg Chem (1997) 1.04
Imaging of enzyme replacement therapy using PET. Proc Natl Acad Sci U S A (2010) 1.03
Oxidation Kinetics of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Water and in Methanol. Inorg Chem (1996) 1.02
Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angew Chem Int Ed Engl (2007) 1.01
Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates. Bioconjug Chem (2011) 1.00
Boon and bane of metal ions in medicine. Science (2003) 0.99
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin. Clin Cancer Res (2008) 0.99
Comparison of bifunctional chelates for (64)Cu antibody imaging. Eur J Nucl Med Mol Imaging (2010) 0.98
Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes. J Inorg Biochem (2004) 0.98
Metallodrugs in medicinal inorganic chemistry. Chem Rev (2014) 0.97
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. J Am Chem Soc (2005) 0.96
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. Dalton Trans (2008) 0.95
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. J Biol Inorg Chem (2002) 0.94
Design of targeting ligands in medicinal inorganic chemistry. Chem Soc Rev (2006) 0.94
Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. J Inorg Biochem (2004) 0.93
Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates. Inorg Chem (2006) 0.93
Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer. Cancer Res (2010) 0.93
Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III). Bioconjug Chem (2005) 0.93
Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration. J Am Chem Soc (2010) 0.93
Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers. Inorg Chem (2005) 0.92
Bis(ligand) Rhenium(V) and Technetium(V) Complexes of Two Naturally Occurring Binding Moieties (Oxazoline and Thiazoline). Inorg Chem (1996) 0.92
Werner coordination chemistry and neurodegeneration. Chem Soc Rev (2012) 0.92
Stoichiometric leverage: rapid 18F-aryltrifluoroborate radiosynthesis at high specific activity for click conjugation. Angew Chem Int Ed Engl (2013) 0.92
Tumour targeting with radiometals for diagnosis and therapy. Chem Commun (Camb) (2013) 0.91
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu. Dalton Trans (2014) 0.91
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. Inorg Chem (2012) 0.91
Carbohydrate conjugates for molecular imaging and radiotherapy: 99mTc(I) and 186Re(I) tricarbonyl complexes of N-(2'-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose. Bioconjug Chem (2004) 0.90
Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J Inorg Biochem (2005) 0.90
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization. Mol Cancer Res (2004) 0.89
H4octapa: an acyclic chelator for 111In radiopharmaceuticals. J Am Chem Soc (2012) 0.88
Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin. Dalton Trans (2015) 0.88
Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin. Breast Cancer Res Treat (2007) 0.87
New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake. Nucl Med Biol (2011) 0.87
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography. BJU Int (2007) 0.86
Molecular architectures for trimetallic d/f/d complexes: structural and magnetic properties of a LnNi2 core. Inorg Chem (2008) 0.86
Evaluation of the H2)dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu. Inorg Chem (2012) 0.85
Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry. Dalton Trans (2009) 0.85
Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats. Mol Cell Biochem (2002) 0.84
A glucosamine-dipicolylamine conjugate of 99mTc(I) and 186Re(I) for use in imaging and therapy. Dalton Trans (2005) 0.83
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Trans (2009) 0.83
Cationic Lanthanide Complexes of N,N'-Bis(2-pyridylmethyl)ethylenediamine-N,N'-diacetic Acid (H(2)bped). Inorg Chem (1997) 0.83
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy. J Am Chem Soc (2013) 0.83
Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies. Inorg Chem (2005) 0.83
(68)Ga small peptide imaging: comparison of NOTA and PCTA. Bioconjug Chem (2012) 0.83
Age and severity of nigrostriatal damage at onset of Parkinson's disease. Synapse (2003) 0.82
H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals. Inorg Chem (2015) 0.81
Vanadium compounds in the treatment of diabetes. Met Ions Biol Syst (2004) 0.81
Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions. Chemistry (2013) 0.80
A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. Bipolar Disord (2005) 0.80
Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin. J Inorg Biochem (2008) 0.80
Studies of the mechanism of the in-loop synthesis of radiopharmaceuticals. Appl Radiat Isot (2004) 0.80
Theoretical studies of the tautomers of pyridinethiones. J Phys Chem A (2008) 0.80
Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. Dalton Trans (2009) 0.79
Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron. Biol Trace Elem Res (2002) 0.79
Characterization of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Solution by EPR Spectroscopy. Inorg Chem (1996) 0.79
Structural, Spectroscopic, Thermodynamic and Kinetic Properties of Copper(II) Complexes with Tripodal Tetraamines. Inorg Chem (1998) 0.79
One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co. Dalton Trans (2011) 0.79
In vitro studies of lanthanide complexes for the treatment of osteoporosis. Dalton Trans (2013) 0.79
Group 13 and lanthanide complexes with mixed O,S anionic ligands derived from maltol. Inorg Chem (2005) 0.79